Segmentectomy for Lung Adenocarcinoma: The Impact of EGFR Mutation Status on Recurrence

被引：0
|
作者：
Hyun, K. [1 ]
Park, S. [1 ]
Lee, H. J. [1 ]
Park, I. K. [2 ]
Kim, Y. [2 ]
Kang, C. H. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Thorac & Cardiovasc Surg, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
segmentectomy; EGFR; Adenocarcinoma;
D O I：
10.1016/j.jtho.2017.09.1828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.16-022
引用
收藏
页码：S2351 / S2351
页数：1
相关论文
共 50 条
  • [21] Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma
    Mohar, B.
    Jezek, S. Smojver
    Molek, K. Rajkovic
    Stemberger, C.
    Kurpis, M.
    Kupanovac, Z.
    Samarzija, M.
    Jonjic, N.
    Grahovac, B.
    CYTOPATHOLOGY, 2016, 27 (06) : 444 - 451
  • [22] The Prognostic Impact of EGFR Mutation Status and Mutation Subtypes in Patients with Surgically Resected Lung Adenocarcinomas
    Takamochi, Kazuya
    Oh, Shiaki
    Matsunaga, Takeshi
    Suzuki, Kenji
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S613 - S614
  • [23] Development and validation of a multivariable predictive model for EGFR gene mutation status in patients with lung adenocarcinoma
    Shi, Yiping
    Zha, Qiongfang
    Ye, Qing
    Xue, Shan
    Wu, Huawei
    Tang, Daoqiang
    Qin, Hui
    Zou, Jing
    NEOPLASMA, 2021, 68 (06) : 1320 - 1330
  • [24] EGFR unusual mutation status in lung adenocarcinomas
    Ana Alarcão
    Vitor Sousa
    Patrícia Couceiro
    Maria Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    BMC Proceedings, 4 (Suppl 2)
  • [25] Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
    Wang, Feng
    Zhao, Ning
    Gao, Ge
    Deng, Hong-Bin
    Wang, Zhi-Hui
    Deng, Li-Li
    Yang, Yu
    Lu, Changlian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2851 - 2859
  • [26] Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
    Hwang, In Kyoung
    Paik, Seung Sook
    Lee, Seung Hyeun
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 158 - 168
  • [27] Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
    Feng Wang
    Ning Zhao
    Ge Gao
    Hong-Bin Deng
    Zhi-Hui Wang
    Li-Li Deng
    Yu Yang
    Changlian Lu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2851 - 2859
  • [28] Correlation Between HLA Alleles and EGFR Mutation in Japanese Patients with Adenocarcinoma of the Lung
    Uramoto, Hidetaka
    So, Tomoko
    Nagata, Yoshika
    Kuroda, Koji
    Shigematsu, Yoshiki
    Baba, Tetsuro
    So, Tetsuya
    Takenoyama, Mitsuhiro
    Hanagiri, Takeshi
    Yasumoto, Kosei
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1136 - 1142
  • [29] COMPARISON OF TWO DIFFERENT EGFR GENE MUTATION TESTS FOR RESECTED LUNG ADENOCARCINOMA
    Takashima, Mika
    Takizawa, Hiromitsu
    Kajiura, Koichiro
    Uyama, Koh
    Toba, Hiroaki
    Nakagawa, Yasushi
    Kawakami, Yukikiyo
    Kenzaki, Koichiro
    Sakiyama, Shoji
    Kondo, Kazuya
    Tangoku, Akira
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1066 - S1066
  • [30] Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma
    Nie, Yunqiang
    Gao, Wei
    Li, Na
    Chen, Wenjun
    Wang, Hui
    Li, Cuiyun
    Zhang, Haiyan
    Han, Ping
    Zhang, Yingmei
    Lv, Xin
    Xu, Xinyi
    Liu, Hongyan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
12345